Stacy Frederick
@sfederick.bsky.social
Science, Biology, Biochemistry & Enzymes
Reposted by Stacy Frederick
Jay Bhattacharya is so dangerously stupid I wouldn't let him shadow me on shift. Others probably feel similarly.
November 15, 2025 at 1:51 AM
Jay Bhattacharya is so dangerously stupid I wouldn't let him shadow me on shift. Others probably feel similarly.
Reposted by Stacy Frederick
The new approach is essentially to stick your head in the sand and go to the gym as a model for pandemic preparedness.
Suffice to say, such a model will not work, but I don't want to belabor the point - I have made it many times already. E.g., here:
bsky.app/profile/kgan...
Suffice to say, such a model will not work, but I don't want to belabor the point - I have made it many times already. E.g., here:
bsky.app/profile/kgan...
I recently gave a talk at Cornell and sat down with Dr. Leifer for her "Immune" podcast. I really enjoyed our wide-ranging conversation, from how I got started in science, how immunity shapes evolution, pandemic risk, and, the current state of US science.
🎧👇
podcasts.apple.com/us/podcast/v...
🎧👇
podcasts.apple.com/us/podcast/v...
Virus-immune Tug-of-war with Kristian Andersen
Podcast Episode · Immune · 11/11/2025 · 1h
podcasts.apple.com
November 14, 2025 at 5:58 PM
The new approach is essentially to stick your head in the sand and go to the gym as a model for pandemic preparedness.
Suffice to say, such a model will not work, but I don't want to belabor the point - I have made it many times already. E.g., here:
bsky.app/profile/kgan...
Suffice to say, such a model will not work, but I don't want to belabor the point - I have made it many times already. E.g., here:
bsky.app/profile/kgan...
Reposted by Stacy Frederick
AViDD was using a similar approach, but this time focused on developing novel anti-viral drugs, with a focus on broad-spectrum drugs. Similar to ReVAMPP, this would give us new drugs against existing pathogens, as well as a new arsenal for emerging ones.
AViDD was canceled.
AViDD was canceled.
November 14, 2025 at 5:58 PM
AViDD was using a similar approach, but this time focused on developing novel anti-viral drugs, with a focus on broad-spectrum drugs. Similar to ReVAMPP, this would give us new drugs against existing pathogens, as well as a new arsenal for emerging ones.
AViDD was canceled.
AViDD was canceled.
Reposted by Stacy Frederick
That means that not only would we have new countermeasures against existing, and highly consequential, pathogens, but we'd be able to pivot existing platforms should a novel species within one of those families emerge.
This is extremely prudent, and frankly, a clever way of doing it.
This is extremely prudent, and frankly, a clever way of doing it.
November 14, 2025 at 5:58 PM
That means that not only would we have new countermeasures against existing, and highly consequential, pathogens, but we'd be able to pivot existing platforms should a novel species within one of those families emerge.
This is extremely prudent, and frankly, a clever way of doing it.
This is extremely prudent, and frankly, a clever way of doing it.
Reposted by Stacy Frederick
ReVAMPP is focused on developing novel vaccines and monoclonals for a whole range of high consequence pathogens using a "prototype" approach. In essence, for each key virus family, select a few prototype viruses and develop new countermeasures against those.
November 14, 2025 at 5:58 PM
ReVAMPP is focused on developing novel vaccines and monoclonals for a whole range of high consequence pathogens using a "prototype" approach. In essence, for each key virus family, select a few prototype viruses and develop new countermeasures against those.
Reposted by Stacy Frederick
There were three programs - ReVAMPP, AViDD, and CREID. ReVAMPP is still active, but the other two have been canceled - I was the PI on one of the canceled CREID centers ("WARN-ID").
November 14, 2025 at 5:58 PM
There were three programs - ReVAMPP, AViDD, and CREID. ReVAMPP is still active, but the other two have been canceled - I was the PI on one of the canceled CREID centers ("WARN-ID").
Reposted by Stacy Frederick
CREID was using a "One Health" approach to perform basic research into all the pathogens out there to gain an understanding of their emergence, spread, and evolution - as well as their pandemic potential, including novel ones.
Again, critically important. And like AViDD, CREID was canceled.
Again, critically important. And like AViDD, CREID was canceled.
November 14, 2025 at 5:58 PM
CREID was using a "One Health" approach to perform basic research into all the pathogens out there to gain an understanding of their emergence, spread, and evolution - as well as their pandemic potential, including novel ones.
Again, critically important. And like AViDD, CREID was canceled.
Again, critically important. And like AViDD, CREID was canceled.
Reposted by Stacy Frederick
Of course, I don't know.
I do know that several people who have worked with him directly have commented to me that one should not overestimate either Memoli's intelligence or his tendency to act ethically or in good faith.
I do know that several people who have worked with him directly have commented to me that one should not overestimate either Memoli's intelligence or his tendency to act ethically or in good faith.
November 17, 2025 at 2:46 PM
Of course, I don't know.
I do know that several people who have worked with him directly have commented to me that one should not overestimate either Memoli's intelligence or his tendency to act ethically or in good faith.
I do know that several people who have worked with him directly have commented to me that one should not overestimate either Memoli's intelligence or his tendency to act ethically or in good faith.
Reposted by Stacy Frederick
Reposted by Stacy Frederick
Reposted by Stacy Frederick
Reposted by Stacy Frederick
